nodes	percent_of_prediction	percent_of_DWPC	metapath
Diazoxide—GLUL—gall bladder—pancreatic cancer	0.0215	0.103	CbGeAlD
Diazoxide—KCNMA1—gall bladder—pancreatic cancer	0.02	0.0954	CbGeAlD
Diazoxide—ATP1A1—Ion transport by P-type ATPases—FXYD3—pancreatic cancer	0.0161	0.108	CbGpPWpGaD
Diazoxide—GLUL—islet of Langerhans—pancreatic cancer	0.0141	0.0674	CbGeAlD
Diazoxide—KCNJ11—islet of Langerhans—pancreatic cancer	0.0133	0.0632	CbGeAlD
Diazoxide—KCNMA1—islet of Langerhans—pancreatic cancer	0.0131	0.0625	CbGeAlD
Diazoxide—ATP1A1—gall bladder—pancreatic cancer	0.0128	0.0613	CbGeAlD
Diazoxide—ABCC8—islet of Langerhans—pancreatic cancer	0.0122	0.0583	CbGeAlD
Diazoxide—GLUL—pancreas—pancreatic cancer	0.00992	0.0474	CbGeAlD
Diazoxide—CA2—gall bladder—pancreatic cancer	0.00984	0.0469	CbGeAlD
Diazoxide—KCNJ11—pancreas—pancreatic cancer	0.00932	0.0445	CbGeAlD
Diazoxide—KCNMA1—pancreas—pancreatic cancer	0.00921	0.0439	CbGeAlD
Diazoxide—KCNJ11—Type II diabetes mellitus—PDX1—pancreatic cancer	0.00881	0.059	CbGpPWpGaD
Diazoxide—ABCC8—pancreas—pancreatic cancer	0.00858	0.0409	CbGeAlD
Diazoxide—GLUL—digestive system—pancreatic cancer	0.00848	0.0404	CbGeAlD
Diazoxide—ATP1A1—islet of Langerhans—pancreatic cancer	0.00842	0.0402	CbGeAlD
Diazoxide—CA1—pancreas—pancreatic cancer	0.00699	0.0334	CbGeAlD
Diazoxide—CA2—islet of Langerhans—pancreatic cancer	0.00645	0.0308	CbGeAlD
Diazoxide—CA1—digestive system—pancreatic cancer	0.00597	0.0285	CbGeAlD
Diazoxide—ATP1A1—pancreas—pancreatic cancer	0.00592	0.0282	CbGeAlD
Diazoxide—ATP1A1—Ion channel transport—FXYD3—pancreatic cancer	0.00559	0.0374	CbGpPWpGaD
Diazoxide—KCNJ11—Type II diabetes mellitus—SLC2A2—pancreatic cancer	0.00556	0.0372	CbGpPWpGaD
Diazoxide—ABCC8—FOXA2 and FOXA3 transcription factor networks—PDX1—pancreatic cancer	0.00522	0.035	CbGpPWpGaD
Diazoxide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—PDX1—pancreatic cancer	0.00506	0.0339	CbGpPWpGaD
Diazoxide—ATP1A1—digestive system—pancreatic cancer	0.00505	0.0241	CbGeAlD
Diazoxide—GLUL—TNF alpha Signaling Pathway—CFLAR—pancreatic cancer	0.00505	0.0338	CbGpPWpGaD
Diazoxide—CA2—pancreas—pancreatic cancer	0.00453	0.0216	CbGeAlD
Diazoxide—CA2—digestive system—pancreatic cancer	0.00387	0.0185	CbGeAlD
Diazoxide—KCNMA1—Platelet homeostasis—PPP2R5B—pancreatic cancer	0.00378	0.0253	CbGpPWpGaD
Diazoxide—ABCC8—FOXA2 and FOXA3 transcription factor networks—SLC2A2—pancreatic cancer	0.00329	0.022	CbGpPWpGaD
Diazoxide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—SLC2A2—pancreatic cancer	0.00319	0.0214	CbGpPWpGaD
Diazoxide—SLC12A3—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00312	0.0209	CbGpPWpGaD
Diazoxide—GLUL—Amino acid and derivative metabolism—ARG2—pancreatic cancer	0.00306	0.0205	CbGpPWpGaD
Diazoxide—ABCC8—Regulation of insulin secretion—GLP1R—pancreatic cancer	0.00225	0.0151	CbGpPWpGaD
Diazoxide—KCNJ11—Regulation of insulin secretion—GLP1R—pancreatic cancer	0.00218	0.0146	CbGpPWpGaD
Diazoxide—ABCC8—Regulation of insulin secretion—SLC2A2—pancreatic cancer	0.0021	0.0141	CbGpPWpGaD
Diazoxide—KCNJ11—Regulation of insulin secretion—SLC2A2—pancreatic cancer	0.00204	0.0137	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00194	0.013	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00194	0.013	CbGpPWpGaD
Diazoxide—Oedema—Sunitinib—pancreatic cancer	0.00183	0.00286	CcSEcCtD
Diazoxide—Pain—Tamoxifen—pancreatic cancer	0.00183	0.00286	CcSEcCtD
Diazoxide—Pain—Erlotinib—pancreatic cancer	0.00181	0.00283	CcSEcCtD
Diazoxide—Thrombocytopenia—Sunitinib—pancreatic cancer	0.0018	0.0028	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—BCL2L1—pancreatic cancer	0.00179	0.012	CbGpPWpGaD
Diazoxide—ABCC8—Integration of energy metabolism—GLP1R—pancreatic cancer	0.00177	0.0119	CbGpPWpGaD
Diazoxide—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00175	0.00273	CcSEcCtD
Diazoxide—Anorexia—Sunitinib—pancreatic cancer	0.00175	0.00273	CcSEcCtD
Diazoxide—Fluid retention—Doxorubicin—pancreatic cancer	0.00173	0.0027	CcSEcCtD
Diazoxide—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00173	0.0027	CcSEcCtD
Diazoxide—KCNJ11—Integration of energy metabolism—GLP1R—pancreatic cancer	0.00172	0.0115	CbGpPWpGaD
Diazoxide—Ill-defined disorder—Irinotecan—pancreatic cancer	0.00172	0.00268	CcSEcCtD
Diazoxide—Abdominal pain—Tamoxifen—pancreatic cancer	0.00169	0.00264	CcSEcCtD
Diazoxide—Lymphadenopathy—Epirubicin—pancreatic cancer	0.00168	0.00262	CcSEcCtD
Diazoxide—Abdominal pain—Erlotinib—pancreatic cancer	0.00167	0.00261	CcSEcCtD
Diazoxide—Body temperature increased—Erlotinib—pancreatic cancer	0.00167	0.00261	CcSEcCtD
Diazoxide—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.00167	0.00261	CcSEcCtD
Diazoxide—Weight increased—Docetaxel—pancreatic cancer	0.00167	0.00261	CcSEcCtD
Diazoxide—Vision blurred—Fluorouracil—pancreatic cancer	0.00167	0.00261	CcSEcCtD
Diazoxide—Malaise—Irinotecan—pancreatic cancer	0.00167	0.0026	CcSEcCtD
Diazoxide—Insomnia—Sunitinib—pancreatic cancer	0.00166	0.00259	CcSEcCtD
Diazoxide—Leukopenia—Irinotecan—pancreatic cancer	0.00166	0.00258	CcSEcCtD
Diazoxide—ABCC8—Integration of energy metabolism—SLC2A2—pancreatic cancer	0.00165	0.0111	CbGpPWpGaD
Diazoxide—Paraesthesia—Sunitinib—pancreatic cancer	0.00165	0.00257	CcSEcCtD
Diazoxide—Malaise—Gemcitabine—pancreatic cancer	0.00163	0.00254	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—NFKBIA—pancreatic cancer	0.00162	0.0109	CbGpPWpGaD
Diazoxide—Leukopenia—Gemcitabine—pancreatic cancer	0.00161	0.00252	CcSEcCtD
Diazoxide—KCNJ11—Integration of energy metabolism—SLC2A2—pancreatic cancer	0.0016	0.0107	CbGpPWpGaD
Diazoxide—Vascular purpura—Epirubicin—pancreatic cancer	0.0016	0.0025	CcSEcCtD
Diazoxide—Hypertension—Irinotecan—pancreatic cancer	0.0016	0.00249	CcSEcCtD
Diazoxide—Decreased appetite—Sunitinib—pancreatic cancer	0.00159	0.00249	CcSEcCtD
Diazoxide—ATP1A1—Preimplantation Embryo—CDH1—pancreatic cancer	0.00159	0.0106	CbGpPWpGaD
Diazoxide—Leukopenia—Fluorouracil—pancreatic cancer	0.00159	0.00247	CcSEcCtD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00159	0.0106	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00159	0.0106	CbGpPWpGaD
Diazoxide—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00158	0.00246	CcSEcCtD
Diazoxide—Pain—Sunitinib—pancreatic cancer	0.00157	0.00245	CcSEcCtD
Diazoxide—ABCC8—Regulation of insulin secretion—GCG—pancreatic cancer	0.00156	0.0105	CbGpPWpGaD
Diazoxide—Discomfort—Irinotecan—pancreatic cancer	0.00156	0.00243	CcSEcCtD
Diazoxide—Hypertension—Gemcitabine—pancreatic cancer	0.00156	0.00243	CcSEcCtD
Diazoxide—Lymphadenopathy—Doxorubicin—pancreatic cancer	0.00155	0.00242	CcSEcCtD
Diazoxide—Asthenia—Tamoxifen—pancreatic cancer	0.00154	0.0024	CcSEcCtD
Diazoxide—Chest pain—Gemcitabine—pancreatic cancer	0.00153	0.00239	CcSEcCtD
Diazoxide—Asthenia—Erlotinib—pancreatic cancer	0.00152	0.00237	CcSEcCtD
Diazoxide—Discomfort—Gemcitabine—pancreatic cancer	0.00152	0.00237	CcSEcCtD
Diazoxide—Pruritus—Tamoxifen—pancreatic cancer	0.00151	0.00236	CcSEcCtD
Diazoxide—KCNJ11—Regulation of insulin secretion—GCG—pancreatic cancer	0.00151	0.0101	CbGpPWpGaD
Diazoxide—Oedema—Irinotecan—pancreatic cancer	0.00151	0.00236	CcSEcCtD
Diazoxide—Chest pain—Fluorouracil—pancreatic cancer	0.00151	0.00235	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—AHR—pancreatic cancer	0.00151	0.0101	CbGpPWpGaD
Diazoxide—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.0015	0.00234	CcSEcCtD
Diazoxide—Pruritus—Erlotinib—pancreatic cancer	0.0015	0.00234	CcSEcCtD
Diazoxide—Discomfort—Fluorouracil—pancreatic cancer	0.00149	0.00233	CcSEcCtD
Diazoxide—Purpura—Epirubicin—pancreatic cancer	0.00149	0.00232	CcSEcCtD
Diazoxide—Vascular purpura—Doxorubicin—pancreatic cancer	0.00148	0.00231	CcSEcCtD
Diazoxide—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00148	0.00231	CcSEcCtD
Diazoxide—Haemoglobin—Docetaxel—pancreatic cancer	0.00148	0.0023	CcSEcCtD
Diazoxide—Oedema—Gemcitabine—pancreatic cancer	0.00147	0.0023	CcSEcCtD
Diazoxide—Haemorrhage—Docetaxel—pancreatic cancer	0.00147	0.00229	CcSEcCtD
Diazoxide—Diarrhoea—Tamoxifen—pancreatic cancer	0.00146	0.00228	CcSEcCtD
Diazoxide—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00146	0.00228	CcSEcCtD
Diazoxide—Abdominal pain—Sunitinib—pancreatic cancer	0.00145	0.00226	CcSEcCtD
Diazoxide—Body temperature increased—Sunitinib—pancreatic cancer	0.00145	0.00226	CcSEcCtD
Diazoxide—Diarrhoea—Erlotinib—pancreatic cancer	0.00145	0.00226	CcSEcCtD
Diazoxide—Oedema—Fluorouracil—pancreatic cancer	0.00145	0.00226	CcSEcCtD
Diazoxide—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00144	0.00225	CcSEcCtD
Diazoxide—Anorexia—Irinotecan—pancreatic cancer	0.00144	0.00225	CcSEcCtD
Diazoxide—Diplopia—Epirubicin—pancreatic cancer	0.00143	0.00224	CcSEcCtD
Diazoxide—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00142	0.00222	CcSEcCtD
Diazoxide—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00142	0.00221	CcSEcCtD
Diazoxide—Dizziness—Tamoxifen—pancreatic cancer	0.00142	0.00221	CcSEcCtD
Diazoxide—Tachycardia—Fluorouracil—pancreatic cancer	0.00141	0.0022	CcSEcCtD
Diazoxide—Hypotension—Irinotecan—pancreatic cancer	0.00141	0.0022	CcSEcCtD
Diazoxide—Anorexia—Gemcitabine—pancreatic cancer	0.0014	0.00219	CcSEcCtD
Diazoxide—Dizziness—Erlotinib—pancreatic cancer	0.0014	0.00218	CcSEcCtD
Diazoxide—Anorexia—Fluorouracil—pancreatic cancer	0.00138	0.00215	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—HES1—pancreatic cancer	0.00138	0.00923	CbGpPWpGaD
Diazoxide—Purpura—Doxorubicin—pancreatic cancer	0.00138	0.00215	CcSEcCtD
Diazoxide—Hypotension—Gemcitabine—pancreatic cancer	0.00137	0.00214	CcSEcCtD
Diazoxide—Insomnia—Irinotecan—pancreatic cancer	0.00137	0.00213	CcSEcCtD
Diazoxide—Flushing—Docetaxel—pancreatic cancer	0.00136	0.00213	CcSEcCtD
Diazoxide—Vomiting—Tamoxifen—pancreatic cancer	0.00136	0.00212	CcSEcCtD
Diazoxide—Paraesthesia—Irinotecan—pancreatic cancer	0.00136	0.00212	CcSEcCtD
Diazoxide—Hypotension—Fluorouracil—pancreatic cancer	0.00135	0.00211	CcSEcCtD
Diazoxide—Hypersensitivity—Sunitinib—pancreatic cancer	0.00135	0.00211	CcSEcCtD
Diazoxide—Rash—Tamoxifen—pancreatic cancer	0.00135	0.00211	CcSEcCtD
Diazoxide—Dermatitis—Tamoxifen—pancreatic cancer	0.00135	0.0021	CcSEcCtD
Diazoxide—Vomiting—Erlotinib—pancreatic cancer	0.00135	0.0021	CcSEcCtD
Diazoxide—Headache—Tamoxifen—pancreatic cancer	0.00134	0.00209	CcSEcCtD
Diazoxide—Rash—Erlotinib—pancreatic cancer	0.00134	0.00208	CcSEcCtD
Diazoxide—Dermatitis—Erlotinib—pancreatic cancer	0.00133	0.00208	CcSEcCtD
Diazoxide—Insomnia—Gemcitabine—pancreatic cancer	0.00133	0.00208	CcSEcCtD
Diazoxide—Headache—Erlotinib—pancreatic cancer	0.00133	0.00207	CcSEcCtD
Diazoxide—Diplopia—Doxorubicin—pancreatic cancer	0.00133	0.00207	CcSEcCtD
Diazoxide—Paraesthesia—Gemcitabine—pancreatic cancer	0.00132	0.00206	CcSEcCtD
Diazoxide—Asthenia—Sunitinib—pancreatic cancer	0.00132	0.00205	CcSEcCtD
Diazoxide—Decreased appetite—Irinotecan—pancreatic cancer	0.00131	0.00205	CcSEcCtD
Diazoxide—ABCC8—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00131	0.00878	CbGpPWpGaD
Diazoxide—Insomnia—Fluorouracil—pancreatic cancer	0.00131	0.00204	CcSEcCtD
Diazoxide—Hypokalaemia—Epirubicin—pancreatic cancer	0.0013	0.00203	CcSEcCtD
Diazoxide—Paraesthesia—Fluorouracil—pancreatic cancer	0.0013	0.00203	CcSEcCtD
Diazoxide—Pruritus—Sunitinib—pancreatic cancer	0.0013	0.00202	CcSEcCtD
Diazoxide—Pain—Irinotecan—pancreatic cancer	0.00129	0.00201	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.00129	0.00201	CcSEcCtD
Diazoxide—Decreased appetite—Gemcitabine—pancreatic cancer	0.00128	0.002	CcSEcCtD
Diazoxide—Nausea—Tamoxifen—pancreatic cancer	0.00127	0.00198	CcSEcCtD
Diazoxide—Pain—Gemcitabine—pancreatic cancer	0.00126	0.00196	CcSEcCtD
Diazoxide—Nausea—Erlotinib—pancreatic cancer	0.00126	0.00196	CcSEcCtD
Diazoxide—Decreased appetite—Fluorouracil—pancreatic cancer	0.00126	0.00196	CcSEcCtD
Diazoxide—KCNJ11—Type II diabetes mellitus—TNF—pancreatic cancer	0.00126	0.00841	CbGpPWpGaD
Diazoxide—Diarrhoea—Sunitinib—pancreatic cancer	0.00125	0.00196	CcSEcCtD
Diazoxide—Feeling abnormal—Irinotecan—pancreatic cancer	0.00124	0.00194	CcSEcCtD
Diazoxide—Pain—Fluorouracil—pancreatic cancer	0.00124	0.00193	CcSEcCtD
Diazoxide—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00124	0.00193	CcSEcCtD
Diazoxide—ABCC8—Integration of energy metabolism—GCG—pancreatic cancer	0.00123	0.00822	CbGpPWpGaD
Diazoxide—Eosinophilia—Epirubicin—pancreatic cancer	0.00123	0.00191	CcSEcCtD
Diazoxide—Pancreatitis—Epirubicin—pancreatic cancer	0.00121	0.00189	CcSEcCtD
Diazoxide—Dizziness—Sunitinib—pancreatic cancer	0.00121	0.00189	CcSEcCtD
Diazoxide—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00121	0.00189	CcSEcCtD
Diazoxide—Hypokalaemia—Doxorubicin—pancreatic cancer	0.00121	0.00188	CcSEcCtD
Diazoxide—Body temperature increased—Irinotecan—pancreatic cancer	0.00119	0.00186	CcSEcCtD
Diazoxide—Abdominal pain—Irinotecan—pancreatic cancer	0.00119	0.00186	CcSEcCtD
Diazoxide—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.00119	0.00186	CcSEcCtD
Diazoxide—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00119	0.00186	CcSEcCtD
Diazoxide—KCNJ11—Integration of energy metabolism—GCG—pancreatic cancer	0.00119	0.00797	CbGpPWpGaD
Diazoxide—SLC12A3—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.00118	0.00789	CbGpPWpGaD
Diazoxide—Vomiting—Sunitinib—pancreatic cancer	0.00117	0.00182	CcSEcCtD
Diazoxide—Body temperature increased—Gemcitabine—pancreatic cancer	0.00116	0.00181	CcSEcCtD
Diazoxide—Rash—Sunitinib—pancreatic cancer	0.00116	0.0018	CcSEcCtD
Diazoxide—Dermatitis—Sunitinib—pancreatic cancer	0.00116	0.0018	CcSEcCtD
Diazoxide—ABCC8—Integration of energy metabolism—STK11—pancreatic cancer	0.00115	0.00773	CbGpPWpGaD
Diazoxide—Headache—Sunitinib—pancreatic cancer	0.00115	0.00179	CcSEcCtD
Diazoxide—Leukopenia—Docetaxel—pancreatic cancer	0.00115	0.00179	CcSEcCtD
Diazoxide—Body temperature increased—Fluorouracil—pancreatic cancer	0.00114	0.00178	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—EZH2—pancreatic cancer	0.00114	0.00762	CbGpPWpGaD
Diazoxide—Eosinophilia—Doxorubicin—pancreatic cancer	0.00113	0.00177	CcSEcCtD
Diazoxide—Palpitations—Docetaxel—pancreatic cancer	0.00113	0.00176	CcSEcCtD
Diazoxide—Weight increased—Epirubicin—pancreatic cancer	0.00113	0.00176	CcSEcCtD
Diazoxide—Pancreatitis—Doxorubicin—pancreatic cancer	0.00112	0.00175	CcSEcCtD
Diazoxide—KCNJ11—Integration of energy metabolism—STK11—pancreatic cancer	0.00112	0.0075	CbGpPWpGaD
Diazoxide—Hyperglycaemia—Epirubicin—pancreatic cancer	0.00112	0.00174	CcSEcCtD
Diazoxide—Hypersensitivity—Irinotecan—pancreatic cancer	0.00111	0.00174	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—CASP3—pancreatic cancer	0.00111	0.00743	CbGpPWpGaD
Diazoxide—Hypertension—Docetaxel—pancreatic cancer	0.0011	0.00172	CcSEcCtD
Diazoxide—Chest pain—Docetaxel—pancreatic cancer	0.00109	0.0017	CcSEcCtD
Diazoxide—Nausea—Sunitinib—pancreatic cancer	0.00109	0.0017	CcSEcCtD
Diazoxide—Asthenia—Irinotecan—pancreatic cancer	0.00108	0.00169	CcSEcCtD
Diazoxide—ABCC8—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00107	0.00716	CbGpPWpGaD
Diazoxide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00107	0.00166	CcSEcCtD
Diazoxide—Sweating—Epirubicin—pancreatic cancer	0.00106	0.00165	CcSEcCtD
Diazoxide—Asthenia—Gemcitabine—pancreatic cancer	0.00106	0.00165	CcSEcCtD
Diazoxide—Haematuria—Epirubicin—pancreatic cancer	0.00105	0.00164	CcSEcCtD
Diazoxide—Oedema—Docetaxel—pancreatic cancer	0.00104	0.00163	CcSEcCtD
Diazoxide—Weight increased—Doxorubicin—pancreatic cancer	0.00104	0.00163	CcSEcCtD
Diazoxide—Pruritus—Gemcitabine—pancreatic cancer	0.00104	0.00162	CcSEcCtD
Diazoxide—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.00103	0.00161	CcSEcCtD
Diazoxide—Diarrhoea—Irinotecan—pancreatic cancer	0.00103	0.00161	CcSEcCtD
Diazoxide—Pruritus—Fluorouracil—pancreatic cancer	0.00102	0.0016	CcSEcCtD
Diazoxide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00102	0.00159	CcSEcCtD
Diazoxide—Tachycardia—Docetaxel—pancreatic cancer	0.00102	0.00159	CcSEcCtD
Diazoxide—Diarrhoea—Gemcitabine—pancreatic cancer	0.00101	0.00157	CcSEcCtD
Diazoxide—Dizziness—Irinotecan—pancreatic cancer	0.000999	0.00156	CcSEcCtD
Diazoxide—Haemoglobin—Epirubicin—pancreatic cancer	0.000996	0.00155	CcSEcCtD
Diazoxide—Anorexia—Docetaxel—pancreatic cancer	0.000995	0.00155	CcSEcCtD
Diazoxide—Haemorrhage—Epirubicin—pancreatic cancer	0.000991	0.00155	CcSEcCtD
Diazoxide—Diarrhoea—Fluorouracil—pancreatic cancer	0.00099	0.00154	CcSEcCtD
Diazoxide—Sweating—Doxorubicin—pancreatic cancer	0.00098	0.00153	CcSEcCtD
Diazoxide—Hypotension—Docetaxel—pancreatic cancer	0.000976	0.00152	CcSEcCtD
Diazoxide—Haematuria—Doxorubicin—pancreatic cancer	0.000974	0.00152	CcSEcCtD
Diazoxide—Vomiting—Irinotecan—pancreatic cancer	0.00096	0.0015	CcSEcCtD
Diazoxide—Dizziness—Fluorouracil—pancreatic cancer	0.000957	0.00149	CcSEcCtD
Diazoxide—Rash—Irinotecan—pancreatic cancer	0.000952	0.00149	CcSEcCtD
Diazoxide—Dermatitis—Irinotecan—pancreatic cancer	0.000952	0.00148	CcSEcCtD
Diazoxide—Headache—Irinotecan—pancreatic cancer	0.000946	0.00148	CcSEcCtD
Diazoxide—Insomnia—Docetaxel—pancreatic cancer	0.000944	0.00147	CcSEcCtD
Diazoxide—Paraesthesia—Docetaxel—pancreatic cancer	0.000938	0.00146	CcSEcCtD
Diazoxide—Vomiting—Gemcitabine—pancreatic cancer	0.000936	0.00146	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—NRAS—pancreatic cancer	0.00093	0.00622	CbGpPWpGaD
Diazoxide—Rash—Gemcitabine—pancreatic cancer	0.000928	0.00145	CcSEcCtD
Diazoxide—Dermatitis—Gemcitabine—pancreatic cancer	0.000927	0.00145	CcSEcCtD
Diazoxide—Haemoglobin—Doxorubicin—pancreatic cancer	0.000922	0.00144	CcSEcCtD
Diazoxide—Headache—Gemcitabine—pancreatic cancer	0.000922	0.00144	CcSEcCtD
Diazoxide—Flushing—Epirubicin—pancreatic cancer	0.00092	0.00144	CcSEcCtD
Diazoxide—Vomiting—Fluorouracil—pancreatic cancer	0.00092	0.00143	CcSEcCtD
Diazoxide—Haemorrhage—Doxorubicin—pancreatic cancer	0.000917	0.00143	CcSEcCtD
Diazoxide—Rash—Fluorouracil—pancreatic cancer	0.000912	0.00142	CcSEcCtD
Diazoxide—Dermatitis—Fluorouracil—pancreatic cancer	0.000911	0.00142	CcSEcCtD
Diazoxide—Decreased appetite—Docetaxel—pancreatic cancer	0.000908	0.00142	CcSEcCtD
Diazoxide—Headache—Fluorouracil—pancreatic cancer	0.000906	0.00141	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—IFNA5—pancreatic cancer	0.000898	0.00601	CbGpPWpGaD
Diazoxide—Nausea—Irinotecan—pancreatic cancer	0.000897	0.0014	CcSEcCtD
Diazoxide—Pain—Docetaxel—pancreatic cancer	0.000893	0.00139	CcSEcCtD
Diazoxide—Nausea—Gemcitabine—pancreatic cancer	0.000874	0.00136	CcSEcCtD
Diazoxide—Feeling abnormal—Docetaxel—pancreatic cancer	0.00086	0.00134	CcSEcCtD
Diazoxide—Nausea—Fluorouracil—pancreatic cancer	0.000859	0.00134	CcSEcCtD
Diazoxide—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000854	0.00133	CcSEcCtD
Diazoxide—Flushing—Doxorubicin—pancreatic cancer	0.000851	0.00133	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—PPP2R5B—pancreatic cancer	0.000848	0.00568	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—CDKN2A—pancreatic cancer	0.000826	0.00553	CbGpPWpGaD
Diazoxide—Body temperature increased—Docetaxel—pancreatic cancer	0.000825	0.00129	CcSEcCtD
Diazoxide—Abdominal pain—Docetaxel—pancreatic cancer	0.000825	0.00129	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—TYMS—pancreatic cancer	0.000824	0.00552	CbGpPWpGaD
Diazoxide—Vision blurred—Epirubicin—pancreatic cancer	0.000813	0.00127	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—TNF—pancreatic cancer	0.000807	0.0054	CbGpPWpGaD
Diazoxide—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000801	0.00125	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—KRAS—pancreatic cancer	0.0008	0.00536	CbGpPWpGaD
Diazoxide—Malaise—Epirubicin—pancreatic cancer	0.000778	0.00121	CcSEcCtD
Diazoxide—Leukopenia—Epirubicin—pancreatic cancer	0.000772	0.0012	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—PTGS2—pancreatic cancer	0.000772	0.00517	CbGpPWpGaD
Diazoxide—Hypersensitivity—Docetaxel—pancreatic cancer	0.000769	0.0012	CcSEcCtD
Diazoxide—Palpitations—Epirubicin—pancreatic cancer	0.000763	0.00119	CcSEcCtD
Diazoxide—Vision blurred—Doxorubicin—pancreatic cancer	0.000753	0.00117	CcSEcCtD
Diazoxide—Asthenia—Docetaxel—pancreatic cancer	0.000749	0.00117	CcSEcCtD
Diazoxide—Hypertension—Epirubicin—pancreatic cancer	0.000745	0.00116	CcSEcCtD
Diazoxide—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000741	0.00116	CcSEcCtD
Diazoxide—Pruritus—Docetaxel—pancreatic cancer	0.000739	0.00115	CcSEcCtD
Diazoxide—Chest pain—Epirubicin—pancreatic cancer	0.000735	0.00115	CcSEcCtD
Diazoxide—Anxiety—Epirubicin—pancreatic cancer	0.000732	0.00114	CcSEcCtD
Diazoxide—Discomfort—Epirubicin—pancreatic cancer	0.000726	0.00113	CcSEcCtD
Diazoxide—Malaise—Doxorubicin—pancreatic cancer	0.00072	0.00112	CcSEcCtD
Diazoxide—Leukopenia—Doxorubicin—pancreatic cancer	0.000715	0.00111	CcSEcCtD
Diazoxide—Diarrhoea—Docetaxel—pancreatic cancer	0.000714	0.00111	CcSEcCtD
Diazoxide—Palpitations—Doxorubicin—pancreatic cancer	0.000706	0.0011	CcSEcCtD
Diazoxide—Oedema—Epirubicin—pancreatic cancer	0.000704	0.0011	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—CCND1—pancreatic cancer	0.000698	0.00467	CbGpPWpGaD
Diazoxide—Dizziness—Docetaxel—pancreatic cancer	0.00069	0.00108	CcSEcCtD
Diazoxide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00069	0.00108	CcSEcCtD
Diazoxide—Hypertension—Doxorubicin—pancreatic cancer	0.000689	0.00108	CcSEcCtD
Diazoxide—Tachycardia—Epirubicin—pancreatic cancer	0.000687	0.00107	CcSEcCtD
Diazoxide—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000681	0.00106	CcSEcCtD
Diazoxide—GLUL—TNF alpha Signaling Pathway—HRAS—pancreatic cancer	0.00068	0.00455	CbGpPWpGaD
Diazoxide—Chest pain—Doxorubicin—pancreatic cancer	0.00068	0.00106	CcSEcCtD
Diazoxide—Anxiety—Doxorubicin—pancreatic cancer	0.000677	0.00106	CcSEcCtD
Diazoxide—Discomfort—Doxorubicin—pancreatic cancer	0.000672	0.00105	CcSEcCtD
Diazoxide—Anorexia—Epirubicin—pancreatic cancer	0.000671	0.00105	CcSEcCtD
Diazoxide—Vomiting—Docetaxel—pancreatic cancer	0.000664	0.00104	CcSEcCtD
Diazoxide—Rash—Docetaxel—pancreatic cancer	0.000658	0.00103	CcSEcCtD
Diazoxide—Hypotension—Epirubicin—pancreatic cancer	0.000658	0.00103	CcSEcCtD
Diazoxide—Dermatitis—Docetaxel—pancreatic cancer	0.000658	0.00103	CcSEcCtD
Diazoxide—Headache—Docetaxel—pancreatic cancer	0.000654	0.00102	CcSEcCtD
Diazoxide—Oedema—Doxorubicin—pancreatic cancer	0.000652	0.00102	CcSEcCtD
Diazoxide—GLUL—Metabolism—PRSS1—pancreatic cancer	0.000649	0.00435	CbGpPWpGaD
Diazoxide—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000638	0.000995	CcSEcCtD
Diazoxide—Insomnia—Epirubicin—pancreatic cancer	0.000637	0.000994	CcSEcCtD
Diazoxide—Tachycardia—Doxorubicin—pancreatic cancer	0.000636	0.000992	CcSEcCtD
Diazoxide—Paraesthesia—Epirubicin—pancreatic cancer	0.000632	0.000986	CcSEcCtD
Diazoxide—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00063	0.000983	CcSEcCtD
Diazoxide—Anorexia—Doxorubicin—pancreatic cancer	0.000621	0.000969	CcSEcCtD
Diazoxide—Nausea—Docetaxel—pancreatic cancer	0.00062	0.000967	CcSEcCtD
Diazoxide—Decreased appetite—Epirubicin—pancreatic cancer	0.000612	0.000955	CcSEcCtD
Diazoxide—Hypotension—Doxorubicin—pancreatic cancer	0.000609	0.00095	CcSEcCtD
Diazoxide—Pain—Epirubicin—pancreatic cancer	0.000602	0.000939	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—NRAS—pancreatic cancer	0.000601	0.00402	CbGpPWpGaD
Diazoxide—GLUL—TNF alpha Signaling Pathway—AKT1—pancreatic cancer	0.0006	0.00402	CbGpPWpGaD
Diazoxide—ATP1A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000599	0.00401	CbGpPWpGaD
Diazoxide—SLC12A3—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000599	0.00401	CbGpPWpGaD
Diazoxide—Insomnia—Doxorubicin—pancreatic cancer	0.000589	0.000919	CcSEcCtD
Diazoxide—Paraesthesia—Doxorubicin—pancreatic cancer	0.000585	0.000913	CcSEcCtD
Diazoxide—KCNMA1—Circadian rythm related genes—PPARG—pancreatic cancer	0.000584	0.00391	CbGpPWpGaD
Diazoxide—Feeling abnormal—Epirubicin—pancreatic cancer	0.00058	0.000905	CcSEcCtD
Diazoxide—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000576	0.000898	CcSEcCtD
Diazoxide—Decreased appetite—Doxorubicin—pancreatic cancer	0.000566	0.000884	CcSEcCtD
Diazoxide—GLUL—Metabolism—ARG2—pancreatic cancer	0.000563	0.00377	CbGpPWpGaD
Diazoxide—CA1—C-MYB transcription factor network—MYC—pancreatic cancer	0.00056	0.00375	CbGpPWpGaD
Diazoxide—Pain—Doxorubicin—pancreatic cancer	0.000557	0.000869	CcSEcCtD
Diazoxide—Body temperature increased—Epirubicin—pancreatic cancer	0.000557	0.000868	CcSEcCtD
Diazoxide—Abdominal pain—Epirubicin—pancreatic cancer	0.000557	0.000868	CcSEcCtD
Diazoxide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	0.000554	0.00371	CbGpPWpGaD
Diazoxide—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000537	0.000838	CcSEcCtD
Diazoxide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	0.000537	0.00359	CbGpPWpGaD
Diazoxide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000533	0.000831	CcSEcCtD
Diazoxide—Hypersensitivity—Epirubicin—pancreatic cancer	0.000519	0.000809	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—KRAS—pancreatic cancer	0.000517	0.00346	CbGpPWpGaD
Diazoxide—Abdominal pain—Doxorubicin—pancreatic cancer	0.000515	0.000804	CcSEcCtD
Diazoxide—Body temperature increased—Doxorubicin—pancreatic cancer	0.000515	0.000804	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—CD44—pancreatic cancer	0.000508	0.0034	CbGpPWpGaD
Diazoxide—Asthenia—Epirubicin—pancreatic cancer	0.000505	0.000788	CcSEcCtD
Diazoxide—Pruritus—Epirubicin—pancreatic cancer	0.000498	0.000777	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—IFNA1—pancreatic cancer	0.000492	0.00329	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—TYMP—pancreatic cancer	0.000492	0.00329	CbGpPWpGaD
Diazoxide—Diarrhoea—Epirubicin—pancreatic cancer	0.000482	0.000752	CcSEcCtD
Diazoxide—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00048	0.000749	CcSEcCtD
Diazoxide—Asthenia—Doxorubicin—pancreatic cancer	0.000468	0.000729	CcSEcCtD
Diazoxide—Dizziness—Epirubicin—pancreatic cancer	0.000466	0.000726	CcSEcCtD
Diazoxide—Pruritus—Doxorubicin—pancreatic cancer	0.000461	0.000719	CcSEcCtD
Diazoxide—KCNMA1—Hemostasis—IFNA2—pancreatic cancer	0.000458	0.00307	CbGpPWpGaD
Diazoxide—Vomiting—Epirubicin—pancreatic cancer	0.000448	0.000698	CcSEcCtD
Diazoxide—Diarrhoea—Doxorubicin—pancreatic cancer	0.000446	0.000695	CcSEcCtD
Diazoxide—Rash—Epirubicin—pancreatic cancer	0.000444	0.000693	CcSEcCtD
Diazoxide—Dermatitis—Epirubicin—pancreatic cancer	0.000444	0.000692	CcSEcCtD
Diazoxide—Headache—Epirubicin—pancreatic cancer	0.000441	0.000688	CcSEcCtD
Diazoxide—CA1—C-MYB transcription factor network—HRAS—pancreatic cancer	0.00044	0.00294	CbGpPWpGaD
Diazoxide—Dizziness—Doxorubicin—pancreatic cancer	0.000431	0.000672	CcSEcCtD
Diazoxide—Nausea—Epirubicin—pancreatic cancer	0.000418	0.000653	CcSEcCtD
Diazoxide—Vomiting—Doxorubicin—pancreatic cancer	0.000414	0.000646	CcSEcCtD
Diazoxide—Rash—Doxorubicin—pancreatic cancer	0.000411	0.000641	CcSEcCtD
Diazoxide—Dermatitis—Doxorubicin—pancreatic cancer	0.000411	0.00064	CcSEcCtD
Diazoxide—Headache—Doxorubicin—pancreatic cancer	0.000408	0.000637	CcSEcCtD
Diazoxide—CA2—Metabolism—PRSS1—pancreatic cancer	0.000407	0.00272	CbGpPWpGaD
Diazoxide—ABCC8—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000404	0.0027	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—PTEN—pancreatic cancer	0.000401	0.00268	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—GLP1R—pancreatic cancer	0.000396	0.00265	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PRSS1—pancreatic cancer	0.00039	0.00261	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—DPYD—pancreatic cancer	0.00039	0.00261	CbGpPWpGaD
Diazoxide—Nausea—Doxorubicin—pancreatic cancer	0.000387	0.000604	CcSEcCtD
Diazoxide—GLUL—Metabolism—SLC2A2—pancreatic cancer	0.00037	0.00248	CbGpPWpGaD
Diazoxide—GLUL—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000365	0.00245	CbGpPWpGaD
Diazoxide—CA2—Metabolism—ARG2—pancreatic cancer	0.000353	0.00236	CbGpPWpGaD
Diazoxide—CA1—Metabolism—ARG2—pancreatic cancer	0.000338	0.00226	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PRSS1—pancreatic cancer	0.000332	0.00222	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—PLAU—pancreatic cancer	0.000325	0.00218	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PRSS1—pancreatic cancer	0.000322	0.00215	CbGpPWpGaD
Diazoxide—CA2—Metabolism—TYMP—pancreatic cancer	0.000308	0.00206	CbGpPWpGaD
Diazoxide—CA1—Metabolism—TYMP—pancreatic cancer	0.000296	0.00198	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—PIK3CG—pancreatic cancer	0.000289	0.00194	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—ARG2—pancreatic cancer	0.000288	0.00193	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—CD44—pancreatic cancer	0.000287	0.00192	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—EGF—pancreatic cancer	0.000286	0.00191	CbGpPWpGaD
Diazoxide—GLUL—Neuronal System—HRAS—pancreatic cancer	0.00028	0.00187	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—ARG2—pancreatic cancer	0.000279	0.00187	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—GCG—pancreatic cancer	0.000275	0.00184	CbGpPWpGaD
Diazoxide—KCNMA1—Circadian rythm related genes—TP53—pancreatic cancer	0.000273	0.00183	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—STK11—pancreatic cancer	0.000258	0.00173	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—PIK3CD—pancreatic cancer	0.000254	0.0017	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—TYMP—pancreatic cancer	0.000251	0.00168	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GLP1R—pancreatic cancer	0.000249	0.00166	CbGpPWpGaD
Diazoxide—CA2—Metabolism—DPYD—pancreatic cancer	0.000244	0.00164	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—TYMP—pancreatic cancer	0.000244	0.00163	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GLP1R—pancreatic cancer	0.000238	0.0016	CbGpPWpGaD
Diazoxide—CA1—Metabolism—DPYD—pancreatic cancer	0.000234	0.00157	CbGpPWpGaD
Diazoxide—CA2—Metabolism—SLC2A2—pancreatic cancer	0.000232	0.00155	CbGpPWpGaD
Diazoxide—CA1—Metabolism—SLC2A2—pancreatic cancer	0.000222	0.00149	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—TYMS—pancreatic cancer	0.000222	0.00149	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—PIK3CB—pancreatic cancer	0.000221	0.00148	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GLP1R—pancreatic cancer	0.000203	0.00136	CbGpPWpGaD
Diazoxide—KCNMA1—Neuronal System—HRAS—pancreatic cancer	0.000201	0.00135	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—DPYD—pancreatic cancer	0.000199	0.00133	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GLP1R—pancreatic cancer	0.000196	0.00132	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—DPYD—pancreatic cancer	0.000193	0.00129	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—SLC2A2—pancreatic cancer	0.000189	0.00127	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—SLC2A2—pancreatic cancer	0.000183	0.00123	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—APOE—pancreatic cancer	0.000181	0.00121	CbGpPWpGaD
Diazoxide—CA2—Metabolism—CD44—pancreatic cancer	0.00018	0.0012	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—SRC—pancreatic cancer	0.000177	0.00119	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—VEGFA—pancreatic cancer	0.000173	0.00116	CbGpPWpGaD
Diazoxide—CA2—Metabolism—GCG—pancreatic cancer	0.000172	0.00115	CbGpPWpGaD
Diazoxide—CA1—Metabolism—CD44—pancreatic cancer	0.000172	0.00115	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—NRAS—pancreatic cancer	0.000171	0.00114	CbGpPWpGaD
Diazoxide—CA1—Metabolism—GCG—pancreatic cancer	0.000165	0.00111	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PIK3CG—pancreatic cancer	0.000163	0.00109	CbGpPWpGaD
Diazoxide—CA2—Metabolism—STK11—pancreatic cancer	0.000162	0.00108	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—TGFB1—pancreatic cancer	0.000159	0.00106	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PPARG—pancreatic cancer	0.000157	0.00105	CbGpPWpGaD
Diazoxide—CA1—Metabolism—STK11—pancreatic cancer	0.000155	0.00104	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—KRAS—pancreatic cancer	0.000147	0.000984	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—CD44—pancreatic cancer	0.000146	0.000981	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PIK3CD—pancreatic cancer	0.000143	0.00096	CbGpPWpGaD
Diazoxide—ABCC8—Neuronal System—HRAS—pancreatic cancer	0.000143	0.000958	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—CD44—pancreatic cancer	0.000142	0.000951	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—GCG—pancreatic cancer	0.00014	0.00094	CbGpPWpGaD
Diazoxide—CA2—Metabolism—TYMS—pancreatic cancer	0.000139	0.000933	CbGpPWpGaD
Diazoxide—KCNJ11—Neuronal System—HRAS—pancreatic cancer	0.000139	0.000929	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—GCG—pancreatic cancer	0.000136	0.000912	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—PIK3CA—pancreatic cancer	0.000135	0.000904	CbGpPWpGaD
Diazoxide—CA1—Metabolism—TYMS—pancreatic cancer	0.000134	0.000894	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—STK11—pancreatic cancer	0.000132	0.000884	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—TP53—pancreatic cancer	0.000131	0.000875	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—STK11—pancreatic cancer	0.000128	0.000857	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PIK3CB—pancreatic cancer	0.000125	0.000837	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—HRAS—pancreatic cancer	0.000125	0.000837	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PTGS2—pancreatic cancer	0.000124	0.000829	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—TYMS—pancreatic cancer	0.000114	0.000761	CbGpPWpGaD
Diazoxide—CA2—Metabolism—APOE—pancreatic cancer	0.000113	0.000759	CbGpPWpGaD
Diazoxide—KCNMA1—Hemostasis—AKT1—pancreatic cancer	0.00011	0.000739	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—TYMS—pancreatic cancer	0.00011	0.000738	CbGpPWpGaD
Diazoxide—CA1—Metabolism—APOE—pancreatic cancer	0.000109	0.000727	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PTEN—pancreatic cancer	0.000108	0.000723	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PIK3CG—pancreatic cancer	0.000102	0.000685	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PPARG—pancreatic cancer	9.87e-05	0.000661	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PIK3CG—pancreatic cancer	9.8e-05	0.000657	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PPARG—pancreatic cancer	9.46e-05	0.000634	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—APOE—pancreatic cancer	9.24e-05	0.000619	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PIK3CD—pancreatic cancer	8.99e-05	0.000602	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—APOE—pancreatic cancer	8.96e-05	0.0006	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PIK3CD—pancreatic cancer	8.62e-05	0.000577	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PIK3CG—pancreatic cancer	8.34e-05	0.000558	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PIK3CG—pancreatic cancer	8.08e-05	0.000541	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PPARG—pancreatic cancer	8.04e-05	0.000539	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PIK3CB—pancreatic cancer	7.84e-05	0.000525	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PPARG—pancreatic cancer	7.8e-05	0.000522	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PTGS2—pancreatic cancer	7.76e-05	0.00052	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—PIK3CA—pancreatic cancer	7.62e-05	0.00051	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PIK3CB—pancreatic cancer	7.51e-05	0.000503	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PTGS2—pancreatic cancer	7.44e-05	0.000498	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PIK3CD—pancreatic cancer	7.33e-05	0.000491	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PIK3CD—pancreatic cancer	7.11e-05	0.000476	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PTEN—pancreatic cancer	6.77e-05	0.000453	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PTEN—pancreatic cancer	6.49e-05	0.000435	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PIK3CB—pancreatic cancer	6.39e-05	0.000428	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PTGS2—pancreatic cancer	6.33e-05	0.000424	CbGpPWpGaD
Diazoxide—GLUL—Metabolism—AKT1—pancreatic cancer	6.22e-05	0.000417	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PIK3CB—pancreatic cancer	6.19e-05	0.000415	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PTGS2—pancreatic cancer	6.14e-05	0.000411	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PTEN—pancreatic cancer	5.52e-05	0.00037	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PTEN—pancreatic cancer	5.35e-05	0.000358	CbGpPWpGaD
Diazoxide—CA2—Metabolism—PIK3CA—pancreatic cancer	4.78e-05	0.00032	CbGpPWpGaD
Diazoxide—CA1—Metabolism—PIK3CA—pancreatic cancer	4.58e-05	0.000307	CbGpPWpGaD
Diazoxide—CA2—Metabolism—AKT1—pancreatic cancer	3.9e-05	0.000261	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—PIK3CA—pancreatic cancer	3.89e-05	0.000261	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—PIK3CA—pancreatic cancer	3.78e-05	0.000253	CbGpPWpGaD
Diazoxide—CA1—Metabolism—AKT1—pancreatic cancer	3.74e-05	0.000251	CbGpPWpGaD
Diazoxide—ABCC8—Metabolism—AKT1—pancreatic cancer	3.18e-05	0.000213	CbGpPWpGaD
Diazoxide—KCNJ11—Metabolism—AKT1—pancreatic cancer	3.08e-05	0.000207	CbGpPWpGaD
